Apotheca Biosciences, Inc. Appointed P.C. Sundar as its Chairman & CEO, effective February 1, 2019. Dr. Sundar, through his years of experience working for Fortune 100 pharmaceutical companies, will lead the Company in discovering, developing, and commercializing cannabinoid-based medicines for Opioid crisis, Neuropathic pain, Cancer, Alzheimer's and Parkinson. Dr. Sundar has over 30 years' executive leadership experience in the pharmaceutical industries.

As the CEO of Apotheca, he brings expertise in growing and scaling businesses, developing winning strategies, operations, marketing, sales and innovation for global businesses and broad brand portfolios. During his 30-year career at Abbott Labs, and Bayer, Sundar held positions of increasing responsibility with strong proven results. Before joining the Apotheca team, Sundar most recently served as a Senior Vice President of a Fortune 50 pharmaceutical company.

He has brought several FDA-approved drugs to market. He also built several collaborative ventures for these companies. Sundar's experience in the pharma sector is helping Apotheca to be a lead player in endocannabinoid drug discovery.